w88win优德中文版 Assisted Lepu Medical in its Issuance of GDRs on the SIX Swiss Exchange
2022.09.21
On September 21, 2022, Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”) successfully issued global depository receipts (“GDRs”) and was officially listed on the SIX Swiss Exchange (this “Project”). 17,684,396 GDRs were issued under this Project, representing 88,421,980 shares of the underlying A-shares, at a final price of USD 12.68 per GDR, raising a total of approximately USD 224 million.
Lepu Medical is the first Chinese medical company to successfully issue GDRs on the SIX Swiss Exchange.
Established in 1999, Lepu Medical was one of the earliest enterprises involved in the R&D and manufacturing of cardiovascular interventional medical devices in China. It is the only national engineering research center for cardiovascular intervention diagnostic devices and equipment to be recognized by the Ministry of Science and Technology, and was one of the first listed enterprises on the ChiNext Shenzhen Stock Exchange in 2009. The company has been deeply engaged in the cardiovascular field for more than 20 years. It focuses on R&D and innovation, and continues to grow and make breakthroughs in the fields of cardiovascular stents, pacemakers, cardiovascular drugs and medical artificial intelligence, and has undertaken many major national scientific research projects. These include the high-tech industrialization demonstration projects of the National Development and Reform Commission, the R&D projects of the Ministry of Science and Technology (863 Program), and projects under the National Key Technology Research and Development Program. Lepu Medical has developed into a leading high-end medical product industry group for cardiovascular implantation and interventional devices and equipment in China, with its business covering four major segments: medical devices, pharmaceutical products, medical services and new medical business.
w88win优德中文版 acted as the PRC counsel to the underwriter, and participated in legal due diligence, internal decision-making procedures, domestic regulatory approval procedures, the preparation of the transaction documents, the review of the prospectus, and the preparation and publication of domestic and overseas announcements. w88win优德中文版’s team assisted Lepu Medical in successfully issuing GDRs and listing on the SIX Swiss Exchange and was unanimously recognized by the company and the other intermediaries for its efficient and rigorous work style and meticulous and professional service attitude.
This Project was led by partners YU, Yongqiang (YY)andTAO, Xudong and was primarily undertaken by Ms. SHI, Yun. Mr.YI, Yisong was responsible for the internal review, and partner DONG, Xiao (Marissa) provided critical assistance at key stages of the project.
